Geiger, N.; Diesendorf, V.; Roll, V.; König, E.-M.; Obernolte, H.; Sewald, K.; Breidenbach, J.; Pillaiyar, T.; Gütschow, M.; Müller, C.E.;
et al. Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. Int. J. Mol. Sci. 2023, 24, 3972.
https://doi.org/10.3390/ijms24043972
AMA Style
Geiger N, Diesendorf V, Roll V, König E-M, Obernolte H, Sewald K, Breidenbach J, Pillaiyar T, Gütschow M, Müller CE,
et al. Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. International Journal of Molecular Sciences. 2023; 24(4):3972.
https://doi.org/10.3390/ijms24043972
Chicago/Turabian Style
Geiger, Nina, Viktoria Diesendorf, Valeria Roll, Eva-Maria König, Helena Obernolte, Katherina Sewald, Julian Breidenbach, Thanigaimalai Pillaiyar, Michael Gütschow, Christa E. Müller,
and et al. 2023. "Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors" International Journal of Molecular Sciences 24, no. 4: 3972.
https://doi.org/10.3390/ijms24043972
APA Style
Geiger, N., Diesendorf, V., Roll, V., König, E.-M., Obernolte, H., Sewald, K., Breidenbach, J., Pillaiyar, T., Gütschow, M., Müller, C. E., & Bodem, J.
(2023). Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. International Journal of Molecular Sciences, 24(4), 3972.
https://doi.org/10.3390/ijms24043972
